Table 2.
No. | Author | Mean age(yr) | Mean FU(months) | Surveillance time of primary MIBC(months) | Quality scale (stars)* |
---|---|---|---|---|---|
1 | Yiou | Primary:62 Secondary:66 |
Primary:49 Secondary:55.3 |
57 | 4 |
2 | Schrier | Primary:63.3 Secondary:68.5 |
NA | NA | 5 |
3 | Lee YH | 62 | 45 | 15 | 5 |
4 | Turkolmez | Primary:59.8 Secondary:60.3 |
Primary:77.8 Secondary:90.3 |
41.7 | 6 |
5 | Lee | Primary:65 Secondary:69 |
Primary:40(median) Secondary:33(median) |
48 | 6 |
6 | de Vries | 61 | 3.4(yr) | NA | 5 |
7 | Rodriguez | 63(median) | 42.5 | NA | 3 |
8 | Kotb | Primary:66.7 Secondary:67.2 |
NA | NA | 4 |
9 | Masson-Lecomte | Primary:66.8 Secondary:68 |
NA | 36 | — |
10 | Hidas | Primary:72.7 Secondary:69.3 |
Primary:40.1 Secondary:52.6 |
44 | 3 |
11 | Aziz | Primary:69 Secondary:71 |
46(median) | 539(d) | 6 |
12 | May | Primary:64.1 Secondary:68.7 |
65 | 661(d) | 7 |
13 | Breau | Primary:67.9 Secondary:67.6 |
NA | 1.8(yr) | 5 |
14 | Moschini | Primary:68 Secondary:67 |
109 | NA | 6 |
NA: not available; MIBC: muscle-invasive bladder cancer; FU: follow-up.
*Number of stars.